Platelet-derived microparticles in patients with high cardiovascular risk and subclinical atherosclerosis

Thromb Haemost 2015; 114(06): 1099
DOI: 10.1160/TH15-09-0720

T&H Insights

Schattauer GmbH

Johann Wojta

¹Department of Internal Medicine II, Core Facilities, Medical University of Vienna, Vienna, Austria

References
1 Burnier L, Fontana P, Kwak BR. et al. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-451.
2 Suades R, Padro T, Alonos R. et al. High levels of TSP1+/CD142+ platelet-derived microparticles characterize young patients with high cardiovascular risk and subclinical atherosclerosis. Thromb Haemost 2015; 114: 1310-1321.
3 Lacroix R, Judicone C, Mooberry M. et al. The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost. 2013 Epub ahead of print.
4 Shantsila E, Montoro-García S, Gallego P. et al. Circulating microparticles: challenges and perspectives of flow cytometric assessment. Thromb Haemost 2014; 111: 1009-1014.